BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20345875)

  • 1. CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility.
    Kristiansen W; Haugen TB; Witczak O; Andersen JM; Fosså SD; Aschim EL
    Int J Androl; 2011 Feb; 34(1):77-83. PubMed ID: 20345875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.
    Kristiansen W; Andreassen KE; Karlsson R; Aschim EL; Bremnes RM; Dahl O; Fosså SD; Klepp O; Langberg CW; Solberg A; Tretli S; Adami HO; Wiklund F; Grotmol T; Haugen TB
    Hum Reprod; 2012 May; 27(5):1525-35. PubMed ID: 22402210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population.
    Pandey SN; Choudhuri G; Mittal B
    Eur J Cancer Prev; 2008 Apr; 17(2):77-81. PubMed ID: 18287863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of CYP1A1*2A in the development of multiple myeloma.
    Kang SH; Kim TY; Kim HY; Yoon JH; Cho HI; Yoon SS; Kang DH; Suh CW; Lee JH; Lee DS
    Acta Haematol; 2008; 119(1):60-4. PubMed ID: 18285692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity.
    Leskelä S; Jara C; Leandro-García LJ; Martínez A; García-Donas J; Hernando S; Hurtado A; Vicario JC; Montero-Conde C; Landa I; López-Jiménez E; Cascón A; Milne RL; Robledo M; Rodríguez-Antona C
    Pharmacogenomics J; 2011 Apr; 11(2):121-9. PubMed ID: 20212519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
    Ishibe N; Hankinson SE; Colditz GA; Spiegelman D; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
    Cancer Res; 1998 Feb; 58(4):667-71. PubMed ID: 9485019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
    Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
    Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women.
    Boyapati SM; Shu XO; Gao YT; Cai Q; Jin F; Zheng W
    Cancer; 2005 Jun; 103(11):2228-35. PubMed ID: 15856430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
    González A; Ramírez V; Cuenca P; Sierra R
    Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
    Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
    Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
    Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors.
    Figueroa JD; Sakoda LC; Graubard BI; Chanock S; Rubertone MV; Erickson RL; McGlynn KA
    Cancer Causes Control; 2008 Nov; 19(9):917-29. PubMed ID: 18415690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of single nucleotide polymorphisms of FSH receptor gene suggests association with testicular cancer susceptibility.
    Ferlin A; Pengo M; Selice R; Salmaso L; Garolla A; Foresta C
    Endocr Relat Cancer; 2008 Jun; 15(2):429-37. PubMed ID: 18430895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
    Shen Y; Li DK; Wu J; Zhang Z; Gao E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP1A1 polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population.
    Sam SS; Thomas V; Reddy SK; Surianarayanan G; Chandrasekaran A
    Head Neck; 2008 Dec; 30(12):1566-74. PubMed ID: 18767181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro.
    Marques CF; Koifman S; Koifman RJ; Boffetta P; Brennan P; Hatagima A
    Oral Oncol; 2006 Jul; 42(6):632-7. PubMed ID: 16488179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
    Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
    Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.